where to next?, page-884

Just a few points.
Can't see how Auscann will gain revenue from the hard shell capsule this year, I think a fair way of having that on market.

Dayacann have had 3 crops & Auscann yet to see a dollar in revenue from that & with Khiron signing on to take the next crops as per recent ann, I wouldn't hold much hope for $$ coming from there soon.

re doctors; your claim of 'we got them on our side'...really not sure about any proof on that, AGH could be only ones to claim that as they have the doctor/prescription numbers to back it up.

I don't agree with claiming 'government red tape greatly reduces our ability to move product', number of other companies moving product already. research will tell you that.
gotta have product to move before can blame other parties for any hold up. How much of Canopy product has been prescribed to patients?
Gov red tape just in access for doctors to patients as well documented.

Don't think any panic selling, just early investors as detailed.

Great news on the CEO though, big salary, largest from pot stocks here. Hope he does well for investors here.